Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Expert Ratings For HashiCorp

HashiCorp (NASDAQ:HCP) has observed the following analyst ratings within the last quarter:

Earnings Outlook For Yatra Online

Earnings Outlook For Yatra Online

Yatra Online (NASDAQ:YTRA) is set to give its latest quarterly earnings report on Friday, 2022-04-01. Here's what investors need to know before the announcement. Analysts estimate that Yatra Online will report an earnings per share (EPS) of $-0.02.

Data Storage Clocks 97% Revenue Growth In Q4 Due To Rising Cyberattacks

Data Storage Clocks 97% Revenue Growth In Q4 Due To Rising Cyberattacks

Business continuity solutions provider Data Storage Corp (NASDAQ:DTST) reported fourth-quarter FY21 revenue growth of 97.1% year-on-year. Data Storage reported FY21 revenue growth of 59.6% Y/Y to $14.9 million. Data Storage achieved positive adjusted EBITDA in Q4 and FY21. The company reported FY21 EPS of $0.03 against $0.02 last year. Data Storage held $12.1 million…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

RVL Pharmaceuticals plc - Ordinary Shares's Return On Capital Employed Insights

Benzinga Pro data, RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) reported Q4 sales of $2.86 million. Earnings fell to a loss of $19.72 million, resulting in a 10.43% decrease from last quarter.

Motorsport Games Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Motorsport Games (NASDAQ:MSGM) reported Q4 sales of $8.22 million. Earnings fell to a loss of $7.00 million, resulting in a 5.12% decrease from last quarter.

Berry (bry)'s Return On Capital Employed Insights

Pulled from Benzinga Pro data, Berry (bry) (NASDAQ:BRY) showed a loss in earnings since Q3, totaling $8.82 million. Sales, on the other hand, increased by 45.09% to $208.09 million during Q4.

Angion Biomedica's Return On Capital Employed Insights

According to Benzinga Pro, during Q4, Angion Biomedica (NASDAQ:ANGN) earned $14.89 million, a 194.82% increase from the preceding quarter. Angion Biomedica also posted a total of $25.94 million in sales, a 1676.78% increase since Q3.

inkl

Read news from The Economist, FT, and more,
with one subscription

Bolt Biotherapeutics's Return On Capital Employed Overview

Bolt Biotherapeutics's Return On Capital Employed Overview

Bolt Biotherapeutics (NASDAQ:BOLT) brought in sales totaling $508.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 16.08%, resulting in a loss of $27.16 million.

Looking Into Icosavax's Return On Capital Employed

Looking Into Icosavax's Return On Capital Employed

According to Benzinga Pro data, during Q4, Icosavax (NASDAQ:ICVX) posted sales of $2.07 million. Earnings were up 47.12%, but Icosavax still reported an overall loss of $18.18 million.

U.S. Well Servs's Return On Capital Employed Insights

U.S. Well Servs's Return On Capital Employed Insights

Benzinga Pro data, U.S. Well Servs (NASDAQ:USWS) reported Q4 sales of $38.93 million. Earnings fell to a loss of $22.74 million, resulting in a 137.44% decrease from last quarter. U.S.

Benzinga's Daily Brief On Trending Tickers For March 31, 2022: Hasbro, Amazon, GameStop And More

Benzinga's Daily Brief On Trending Tickers For March 31, 2022: Hasbro, Amazon, GameStop And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. The data on the trending tickers is compiled from a list of most-discussed tickers on the popular Reddit forum WallStreetBets.

Looking Into Miromatrix Medical's Return On Capital Employed

Looking Into Miromatrix Medical's Return On Capital Employed

Benzinga Pro data, Miromatrix Medical (NASDAQ:MIRO) reported Q4 sales of $8.00 thousand. Earnings fell to a loss of $5.48 million, resulting in a 8.27% decrease from last quarter.

Acutus Medical Earnings Perspective: Return On Capital Employed

Acutus Medical Earnings Perspective: Return On Capital Employed

Acutus Medical (NASDAQ:AFIB) brought in sales totaling $4.36 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 9.66%, resulting in a loss of $31.26 million.

Looking Into PolarityTE's Return On Capital Employed

Looking Into PolarityTE's Return On Capital Employed

Benzinga Pro data, PolarityTE (NASDAQ:PTE) reported Q4 sales of $1.04 million. Earnings fell to a loss of $8.57 million, resulting in a 739.18% decrease from last quarter.

Get all your
news in one place.

100’s of premium titles.
One news app.

ATAI Life Sciences's Return On Capital Employed Insights

ATAI Life Sciences (NASDAQ:ATAI) brought in sales totaling $230.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 194.78%, resulting in a loss of $93.27 million.

Five Below Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q4, Five Below (NASDAQ:FIVE) earned $140.20 million, a 479.87% increase from the preceding quarter. Five Below also posted a total of $996.33 million in sales, a 63.97% increase since Q3.

Arhaus Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data Arhaus (NASDAQ:ARHS) posted a 55.84% decrease in earnings from Q3. Sales, however, increased by 17.16% over the previous quarter to $238.23 million.

Why Longeveron Shares Are Surging Today

Longeveron Inc (NASDAQ: LGVN) shares are trading higher Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with mild Alzheimer's disease in "Alzheimer's & Dementia: The Journal of the Alzheimer's Association."

Get all your
news in one place.

100’s of premium titles.
One news app.

Agile Therapeutics's Return On Capital Employed Insights

Benzinga Pro data, Agile Therapeutics (NASDAQ:AGRX) reported Q4 sales of $1.51 million. Earnings fell to a loss of $23.36 million, resulting in a 39.26% decrease from last quarter.

Motus GI Hldgs's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q4, Motus GI Hldgs's (NASDAQ:MOTS) reported sales totaled $99.00 thousand. Despite a 0.12% increase in earnings, the company posted a loss of $4.82 million.

vTv Therapeutics's Return On Capital Employed Overview

vTv Therapeutics (NASDAQ:VTVT) brought in sales totaling $9.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 547.3%, resulting in a loss of $9.48 million.

Here's How This Bitcoin Mining Company Fared In FY21

Bitcoin mining company Sphere 3D Corp (NASDAQ:ANY) reported an FY21 revenue decline of 23.3% year-on-year to $3.72 million. The gross margin contracted 80 bps to 45.6%. Operating expenses more than doubled to $21.4 million. EPS loss was $(0.58) versus $(0.98) last year. Sphere 3D held $54.4 million in cash and equivalents. CEO Peter Tassiopoulos…

Celsion: Q4 Earnings Insights

Celsion (NASDAQ:CLSN) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Recap: Bassett Furniture Q1 Earnings

Bassett Furniture Indus (NASDAQ:BSET) reported its Q1 earnings results on Thursday, March 31, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

Galectin Therapeutics: Q4 Earnings Insights

Galectin Therapeutics (NASDAQ:GALT) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

1 … 737 738 739 740

Organisations

Core Scientific

Motorsport Games

ATAI Life Sciences

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play